Sökning: "Biochemical markers"
Visar resultat 21 - 25 av 185 avhandlingar innehållade orden Biochemical markers.
21. Search for reliable diagnostic markers for Alzheimer’s disease
Sammanfattning : The diagnosis of Alzheimer’s disease (AD) is rather difficult not at least in the earlier stages of the disease. The diagnostic accuracy has been reported to be around 65-90%. These figures however, come from academic centers with a special interest in the disease and are based on patients followed for several years. LÄS MER
22. Mesothelial differentiation, mesothelioma and tumor markers in serous cavities
Sammanfattning : Mesothelial cells covering the serous membranes are of mesodermal origin although they acquire several characteristics of epithelial cells. The cytological and histological diagnosis of malignant tumors in serous cavities is sometimes a major challenge: the main diagnostic alternatives are reactive benign mesothelium, mesothelioma and adenocarcinoma. LÄS MER
23. Diabetes in Young Adults : Remission, β-cell function and markers of inflammation
Sammanfattning : Type 1 diabetes is caused by immuno-mediated β-cell destruction leading to insulin deficiency and hyperglycaemia. The decline in β-cell function and the clinical course after diagnosis vary. Whether the process of destruction of the β-cells is associated with markers of a non-specific inflammatory response is unknown. LÄS MER
24. Markers of inflammation and neurodegeneration in muliple sclerosis
Sammanfattning : The main line of my thesis projects is searching for biomarkers and evidence of optimal correlation with clinical and para-clinical outcome measurements in multiple sclerosis (MS): investigating the biochemical biomarker in blood/plasma (cerebrosterol) and in cerebrospinal fluid (CSF) (oligoclonal bands (OCB)) and the correlation with MRI lesion load (paper 1 and paper IV); investigating the genetic biomarker (CYP46A1) for susceptibility and disability progression in MS (Paper III); comparison of the well-known positron emission tomography (PET) ligand and peripheral benzodiazepine receptor (PBR) antagonist, [11C]PK11195, and a new PET ligand [11C]vinpocetine (tissue receptor biomarker). Both ligands denote areas of active ongoing inflammation in MS (paper II). LÄS MER
25. Biochemical markers of myocardial damage for early diagnosis and prognosis in patients with acute coronary syndromes
Sammanfattning : .... LÄS MER